Intelligence Β· Patent portfolio
United Therapeutics Europe Patents
Full USPTO pharma patent portfolio for United Therapeutics Europe β grant dates, expiration, and drug cross-links.
- Patents
- 3,720
- Expiring β€24m
- 234
Quick answer
United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β use filters for patent-cliff planning.
-
US 6410537
Compositions having neuroprotective and analgesic activity
expired -
US 6410023
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
expired -
US 6406887
Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection
expired -
US 6403635
Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
expired -
US 6403094
Clostridium perfringens vaccines
expired -
US 6403769
Fusion proteins that include antibody and nonantibody portions
expired -
US 6403576
Antifungal and antiparasitic compounds
expired -
US 6403100
Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated
expired -
US 6403653
Active topical skin protectants using reactive nanoparticles
expired -
US 6399062
Murine monoclonal antibody protective against Plasmodium vivax malaria
expired -
US 6399332
Bacterial superantigen vaccines
expired -
US 6399743
Isolation and characterization of a rat epidermal growth factor related protein
expired -
US 6392026
Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
expired -
US 6391651
Materials and methods for detection of insulin dependent diabetes
expired -
US 6387363
Biocompatible medical devices
expired -
US 6387389
Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use
expired -
US 6387662
Synthesis and purification of hepatitis C virus-like particles
expired -
US 6387399
Microencapsulated bioactive agents and method of making
expired -
US 6384206
Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
expired -
US 6379891
Method of detecting HEV infection
expired -
US 6379697
Stabilization of photosensitive materials
expired -
US 6379660
Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and composition comprising same
expired -
US 6379677
Streptococcus iniae vaccine
expired -
US 6375962
Barrier cream comprising hexamethylenetetramine or derivative thereof
expired -
US 6376659
Nucleic acids encoding a novel neutrophil chemotactic factor
expired -
US 6375894
Acid assisted cold welding and intermetallic formation and dental applications thereof
expired -
US 6368662
Molecular level coating of metal oxide particles
expired -
US 6369235
Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection
expired -
US 6365712
Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 &agr; subunit
expired -
US 6365616
Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
expired -
US 6361992
Thyroid stimulating hormone superagonists
expired -
US 6361968
Extension of a protein-protein interaction surface to inactive the function of a cellular protein
expired -
US 6358736
Method for increasing the antigen presenting ability of leukemia cells
expired -
US 6355610
Inhibitors of formation of protease resistant prion protein
expired -
US 6353097
Nucleic acids encoding signal transduction inhibitors of allergic reactions
expired -
US 6353019
Macrocyclic lactones, compositions, and methods of use
expired -
US 6346236
Sunscreens from vegetable oil and plant phenols
expired -
US 6342390
Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
expired -
US 6342392
Nucleotide and deduced amino acid sequences of tumor gene Int6
expired -
US 6342222
Equine arteritis virus peptides, antibodies and their use in a diagnostic test
expired -
US 6339102
Method and composition for treating and preventing retinal damage
expired -
US 6335428
Agents that bind to and inhibit human cytochrome P450 1A2
expired -
US 6333331
Substituted O6-benzylguanines
expired -
US 6331630
Dimeric arylisoquinoline alkaloids and derivatives thereof
expired -
US 6328197
Aerosol dispensing container and method for manufacturing same
expired -
US 6328959
Intestinal hydrogen removal using hydrogen-metabolizing microbes
expired -
US 6329349
Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
expired -
US 6326394
Calixarene tubes as cation receptors
expired
Frequently asked questions
How many patents does United Therapeutics Europe have?
3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do United Therapeutics Europe patents expire?
234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory